<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">690318</article-id><article-id pub-id-type="doi">10.26442/20751753.2026.7.203589</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Reproductive prognosis after laparoscopic cystectomy in endometrioid ovarian cysts: the significance of clinical and laboratory parameters</article-title><trans-title-group xml:lang="ru"><trans-title>Репродуктивный прогноз после лапароскопической цистэктомии при эндометриоидных кистах яичников: значение клинических и лабораторных параметров</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2797-1926</contrib-id><name-alternatives><name xml:lang="en"><surname>Kudryavtseva</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Кудрявцева</surname><given-names>Елена Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Assoc. Prof.</p></bio><bio xml:lang="ru"><p>д-р мед. наук, доц., проф. каф. акушерства и гинекологии</p></bio><email>elenavladpopova@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3413-1685</contrib-id><name-alternatives><name xml:lang="en"><surname>Mangileva</surname><given-names>Yana A.</given-names></name><name xml:lang="ru"><surname>Мангилева</surname><given-names>Яна Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Obst./Gyn.</p></bio><bio xml:lang="ru"><p>врач – акушер-гинеколог</p></bio><email>elenavladpopova@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0761-2785</contrib-id><name-alternatives><name xml:lang="en"><surname>Potapov</surname><given-names>Nikolay N.</given-names></name><name xml:lang="ru"><surname>Потапов</surname><given-names>Николай Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, зав. отд-нием гинекологии №2</p></bio><email>elenavladpopova@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8640-8418</contrib-id><name-alternatives><name xml:lang="en"><surname>Kovalev</surname><given-names>Vladislav V.</given-names></name><name xml:lang="ru"><surname>Ковалев</surname><given-names>Владислав Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof.</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф., зав. каф. акушерства и гинекологии</p></bio><email>elenavladpopova@yandex.ru</email><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Ural Research Institute of Maternal and Child Health</institution></aff><aff><institution xml:lang="ru">ФГБУ «Уральский научно-исследовательский институт охраны материнства и младенчества» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">European Medical Center «UMMC-Health» LLC</institution></aff><aff><institution xml:lang="ru">ООО «Европейский медицинский центр "УГМК-Здоровье"»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">City Clinical Hospital No. 40</institution></aff><aff><institution xml:lang="ru">ГАУЗ СО «Городская клиническая больница №40»</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Ural State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Уральский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2026-07-16" publication-format="electronic"><day>16</day><month>07</month><year>2026</year></pub-date><volume>28</volume><issue>7</issue><issue-title xml:lang="en">Women’s and men’s health</issue-title><issue-title xml:lang="ru">Женское и мужское здоровье</issue-title><fpage>525</fpage><lpage>531</lpage><history><date date-type="received" iso-8601-date="2025-09-12"><day>12</day><month>09</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-11-01"><day>01</day><month>11</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/690318">https://consilium.orscience.ru/2075-1753/article/view/690318</self-uri><abstract xml:lang="en"><p><bold>Background. </bold>The relevance is due to the high frequency of fertility disorders in patients with endometrioid ovarian cysts, the limitations of existing methods for predicting pregnancy, and the need for an individual approach to managing such patients.</p> <p><bold>Aim. </bold>To evaluate the prognostic significance of clinical and laboratory parameters in predicting the likelihood of pregnancy in women who underwent surgical treatment for endometrioid ovarian cyst.</p> <p><bold>Materials and methods. </bold>A prospective comparative study of 88 patients operated on for newly diagnosed unilateral endometrioid ovarian cyst was conducted. The patients were followed up for 6 months after surgery and were divided into 2 groups: group 1 – 55 women without pregnancy, group 2 – 33 women with spontaneous pregnancy. Before the operation, all patients underwent ultrasound of the pelvic organs, analysis of the content of sex hormones, standard laboratory tests, evaluation of the visual-analog pain scale. During the operation, peritoneal fluid was taken to determine the levels of vascular endothelial growth factor, tumor necrosis factor α (TNF-α), interleukins-1β, 6, 8, 10.</p> <p><bold>Results. </bold>The level of Anti-Mullerian hormone was lower in group 1 – 2.55 [Q<sub>1</sub>–Q<sub>3</sub> 1.25–4.33] ng/ml, compared with group 2 – 4.40 [Q<sub>1</sub>–Q<sub>3</sub> 2.10–6.90] ng/ml; <italic>p</italic>=0.028. The level of ferritin was also lower in group 1 – 29 [Q<sub>1</sub>–Q<sub>3</sub> 14.75–57] mcg/l, compared with group 2 – 41 [Q<sub>1</sub>–Q<sub>3</sub> 22–57] mcg/l (<italic>p</italic>=0.023). The frequency of detection of ultrasound signs of adenomyosis was higher in group 1 – in 27 (49.1%) women, compared with group 2 – in 9 (27.3%); <italic>p</italic>=0.044. The Endometriosis Fertility Index (EFI) was 7 [Q<sub>1</sub>–Q<sub>3</sub> 7–8] points for group 1 and 9 [Q<sub>1</sub>–Q<sub>3</sub> 8–9] points for group 2 (<italic>p</italic>&lt; 0.001). The concentration of TNF-α in the peritoneal fluid was 3.51 [Q<sub>1</sub>–Q<sub>3</sub> 1.37–4.18] pg/ml in group 1, compared with group 2 – 2.46 [Q<sub>1</sub>–Q<sub>3</sub> 0.66–3.73] pg/ml (<italic>p</italic>=0.036).</p> <p><bold>Conclusion. </bold>The study revealed that successful conception was associated with high serum levels of Anti-Mullerian hormone and ferritin, low concentrations of TNF-α in peritoneal fluid, and absence of adenomyosis on ultrasound examination.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование. </bold>Актуальность исследования обусловлена высокой частотой нарушения фертильности у пациенток с эндометриоидными кистами яичников (ЭКЯ), ограничением существующих методов прогнозирования наступления беременности и необходимостью индивидуального подхода ведения таких пациенток.</p> <p><bold>Цель. </bold>Оценить прогностическую значимость клинических и лабораторных показателей в предсказании вероятности наступления беременности у женщин, перенесших хирургическое лечение ЭКЯ.</p> <p><bold>Материалы и методы. </bold>Проведено проспективное сравнительное исследование 88 пациенток, прооперированных по поводу впервые выявленной односторонней ЭКЯ. Пациенток наблюдали в течение 6 мес после операции и разделили на 2 группы: группа 1 – 55 женщин без наступления беременности, группа 2 – 33 женщины со спонтанной беременностью. Перед операцией всем пациенткам проводили ультразвуковое исследование органов малого таза, анализ содержания половых гормонов, стандартные лабораторные анализы, оценку Визуальной аналоговой шкалы боли. Во время операции производили забор перитонеальной жидкости (ПЖ) для определения уровней васкулоэндотелиального фактора роста, фактора некроза опухоли α (ФНО-α), интерлейкинов-1β, 6, 8, 10.</p> <p><bold>Результаты. </bold>Уровень антимюллерова гормона был ниже в группе 1 – 2,55 [Q<sub>1</sub>–Q<sub>3</sub> 1,25–4,33] нг/мл, по сравнению с группой 2 – 4,40 [Q<sub>1</sub>–Q<sub>3</sub> 2,10–6,90] нг/мл; <italic>p</italic>=0,028. Уровень ферритина также был ниже в группе 1 – 29 [Q<sub>1</sub>–Q<sub>3</sub> 14,75–57] мкг/л, по сравнению с группой 2 – 41 [Q<sub>1</sub>–Q<sub>3</sub> 22–57] мкг/л (<italic>р</italic>=0,023). Частота выявления ультразвуковых признаков аденомиоза была выше в группе 1 – у 27 (49,1%) женщин, по сравнению с группой 2 – у 9 (27,3%); <italic>р</italic>=0,044. Индекс фертильности при эндометриозе (Endometriosis Fertility Index – EFI) составил 7 [Q<sub>1</sub>–Q<sub>3</sub> 7–8] баллов для группы 1 и 9 [Q<sub>1</sub>–Q<sub>3</sub> 8–9] баллов для группы 2 (<italic>р</italic>&lt; 0,001). Концентрация ФНО-α в ПЖ составила 3,51 [Q<sub>1</sub>–Q<sub>3</sub> 1,37–4,18] пг/мл в группе 1, тогда как в группе 2 – 2,46 [Q<sub>1</sub>–Q<sub>3</sub> 0,66–3,73] пг/мл (<italic>p</italic>=0,036).</p> <p><bold>Заключение. </bold>Исследование выявило связь успешного зачатия с высокими уровнями антимюллерова гормона и ферритина в сыворотке крови, низким содержанием ФНО-α в ПЖ и отсутствием аденомиоза по данным ультразвукового исследования.</p></trans-abstract><kwd-group xml:lang="en"><kwd>endometrioid ovarian cysts</kwd><kwd>ovarian reserve</kwd><kwd>endometriosis fertility index</kwd><kwd>peritoneal fluid</kwd><kwd>tumor necrosis factor α</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>эндометриоидные кисты яичников</kwd><kwd>овариальный резерв</kwd><kwd>индекс фертильности</kwd><kwd>перитонеальная жидкость</kwd><kwd>фактор некроза опухоли α</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Nezhat FR, Cathcart AM, Nezhat CH, Nezhat CR. Pathophysiology and Clinical Implications of Ovarian Endometriomas. Obstet Gynecol. 2024;143(6):759-66. DOI:10.1097/AOG.0000000000005587</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Sini I, Joe A, Handayani N, et al. Optimizing infertility treatment for ovarian endometrioma: is surgical intervention preferable before or after in-vitro fertilization programs? Arch Gynecol Obstet. 2025;311(3):781-7. DOI:10.1007/s00404-025-07954-3</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Дубровина С.О., Берлим Ю.Д., Александрина А.Д., и др. Современные представления о диагностике и лечении эндометриоза. Акушерство и Гинекология. 2023:146-53 [Dubrovina SO, Berlim YuD, Aleksandrina AD, et al. Modern ideas about the diagnosis and treatment of endometriosis. Obstetrics and Gynecology. 2023:146-53 (in Russian)]. DOI:10.18565/aig.2023.43</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244-56. DOI:10.1056/NEJMra1810764</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Muzii L, Galati G, Mattei G, et al. Expectant, Medical, and Surgical Management of Ovarian Endometriomas. J Clin Med. 2023;12(5):1858. DOI:10.3390/jcm12051858</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Daniilidis A, Grigoriadis G, Kalaitzopoulos DR, et al. Surgical Management of Ovarian Endometrioma: Impact on Ovarian Reserve Parameters and Reproductive Outcomes. J Clin Med. 2023;12(16):5324. DOI:10.3390/jcm12165324</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Anh ND, Ha NTT, Tri NM, et al. Long-Term Follow-Up Of Anti-Mullerian Hormone Levels After Laparoscopic Endometrioma Cystectomy. Int J Med Sci. 2022;19(4):651-8. DOI:10.7150/ijms.69830</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Jiang D, Nie X. Effect of endometrioma and its surgical excision on fertility (Review). Exp Ther Med. 2020;20(5):114. DOI:10.3892/etm.2020.9242</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Adamson GD, Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril. 2010;94(5):1609-15. DOI:10.1016/j.fertnstert.2009.09.035</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bailleul A, Niro J, Du Cheyron J, et al. Infertility management according to the Endometriosis Fertility Index in patients operated for endometriosis: What is the optimal time frame? PLoS One. 2021;16(5):e0251372. DOI:10.1371/journal.pone.0251372</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Zhou Y, Lin L, Chen Z, et al. Fertility performance and the predictive value of the endometriosis fertility index staging system in women with recurrent endometriosis: A retrospective study. Medicine (Baltimore). 2019;98(39):e16965. DOI:10.1097/MD.0000000000016965</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Demir E, Soyman Z, Kelekci S. Outcomes between non-IVF and IVF treatment after laparoscopic conservative surgery of advanced endometriosis with Endometriosis Fertility Index score &gt;3. Medicine (Baltimore). 2022;101(37):e30602. DOI:10.1097/MD.0000000000030602</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Park HJ, Kim H, Lee GH, et al. Could surgical management improve the IVF outcomes in infertile women with endometrioma?: a review. Obstet Gynecol Sci. 2019;62(1):1-10. DOI:10.5468/ogs.2019.62.1.1</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Harmsen MJ, Van den Bosch T, de Leeuw RA, et al. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure. Ultrasound Obstet Gynecol. 2022;60(1):118-31. DOI:10.1002/uog.24786</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Cranney R, Condous G, Reid S. An update on the diagnosis, surgical management, and fertility outcomes for women with endometrioma. Acta Obstet Gynecol Scand. 2017;96(6):633-43. DOI:10.1111/aogs.13114</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Santulli P, Bourdon M, Desportes C, et al. Assessment of the Pelvic Pain Experienced by Infertile Women is of Prime Importance for Diagnosing Endometriosis. J Minim Invasive Gynecol. 2024;31(11):943-950.e1. DOI:10.1016/j.jmig.2024.07.010</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Kovačević VM, Anđelić LM, Mitrović Jovanović A. Changes in serum antimüllerian hormone levels in patients 6 and 12 months after endometrioma stripping surgery. Fertil Steril. 2018;110(6):1173-80. DOI:10.1016/j.fertnstert.2018.07.019</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Tulenheimo-Silfvast A, Ruokolainen-Pursiainen L, Simberg N. Association between iron deficiency and fertility. Acta Obstet Gynecol Scand. 2025;104(4):738-45. DOI:10.1111/aogs.15046</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Кудрявцева Е.В., Мангилева Я.А., Полушина Л.Г., и др. Исследование уровней биомаркеров воспаления и ангиогенеза в различных биологических жидкостях у женщин с наружным генитальным эндометриозом. Акушерство и Гинекология. 2025;7:112-20 [Kudryavtseva EV, Mangileva YaA, Polushina LG, et al. Study of inflammatory and angiogenic biomarker levels in various biological fluids in women with extragenital endometriosis. Obstetrics and Gynecology. 2025;7:112-20 (in Russian)]. DOI:10.18565/aig.2025.116.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Мангилева Я.А., Чижова А.В., Кудрявцева Е.В., и др. Значение состава перитонеальной жидкости в генезе бесплодия у женщин с эндометриозом яичников. Вестник уральской медицинской академической науки. 2022;19(2):82-94 [Mangileva JaA, Chizhova AV, Kudrjavceva EV, et al. The significance of peritonial fluid in the genesis of infertility in women with ovarian endometriosis. Journal of Ural Medical Academic Science. 2022;19(2):82-94 (in Russian)]. DOI:10.22138/2500-0918-2022-19-2-82-94</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Li W, Lin A, Qi L, et al. Immunotherapy: A promising novel endometriosis therapy. Front Immunol. 2023;14:1128301. DOI:10.3389/fimmu.2023.1128301</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Liu M, Li Y, Yuan Y, et al. Peri-implantation treatment with TNF-α inhibitor for endometriosis and/or adenomyosis women undergoing frozen-thawed embryo transfer: A retrospective cohort study. J Reprod Immunol. 2025;167:104415. DOI:10.1016/j.jri.2024.104415</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Corachán A, Pellicer N, Pellicer A, Ferrero H. Novel therapeutic targets to improve IVF outcomes in endometriosis patients: a review and future prospects. Hum Reprod Update. 2021;27(5):923-72. DOI:10.1093/humupd/dmab014</mixed-citation></ref></ref-list></back></article>
